Healio
Healio
Yellow awareness ribbon along with image of uterus

Uterine Fibroid Awareness

In this video exclusive, experts discuss recent advancements in the treatment of uterine fibroids, methods for screening for the condition, insight on treatment plans, and other topics.

Choose a Section
  • Erica Marsh, MD

    • Erica Marsh, MD

    In a video interview, Erica Elizabeth Marsh, MD, MSCI, professor of obstetrics and gynecology and chief of the division of reproductive endocrinology and infertility at the University of Michigan Medical School, discussed:

    • recent advancements in uterine fibroid treatment, including radiological interventions and MRI-guided focused ultrasound treatments;
    • evolving understanding of uterine fibroid risk factors, specifically age and race, along with “protective” risk factors that are associated with lower risk;
    • methods to screen for uterine fibroids, along with challenges for how to help patients recognize symptoms and information crucial to creating a productive relationship between patient and provider;
    • new classes of medications for fibroids, including GnRH antagonist, an oral-based medication that reduces the flow of estrogen and progesterone to help prevent fibroids;
    • and how treatment plans should differ between patients, including what to take into account and what risk factors to consider, and how a patient’s desires are the most important factor.